SCHEMBL24994721

SCHEMBL24994721

CCOc1ccc(-c2nc(C(=O)OC)cnc2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ KDM4E B2RXH2 5/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ MAPT P10636 6/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HPGD P15428 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ CNR1 P21554 3/20 0.43
▸ SCN2A Q99250 1/20 0.43
▸ SCN10A Q9Y5Y9 1/20 0.43
▸ POLB P06746 1/20 0.41
▸ AHR P35869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24994723 0.86 ALDH1A1 (0.48) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24994714 0.86 NPC1 (0.46) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24994733 0.86 NPC1 (0.46) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24994722 0.86 NPC1 (0.46) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24993372 0.86 ALDH1A1 (0.56) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24994725 0.83 KDM4E (0.45) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL24994319 0.77 SCN10A (0.64) RAB9ANPC1KDM4ENPSR1MAPT
SCHEMBL24993600 0.76 NPC1 (0.53) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL9695575 0.76 CNR1 (0.66) KMT2AKDM4EMAPTALDH1A1GAA
SCHEMBL30925922 0.76 MEN1 (0.48) RAB9ANPC1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback